[HTML] frontiersin.org

[HTML][HTML] Potential for ketotherapies as amyloid-regulating treatment in individuals at risk for Alzheimer's disease

MK Taylor, DK Sullivan, JE Keller, JM Burns… - Frontiers in …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by
clinical decline in memory and other cognitive functions. A classic AD neuropathological …
被引用次数：10 相关文章

Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer's Disease.

MK Taylor, DK Sullivan, JE Keller… - Frontiers in …, 2022 - search.ebscohost.com
Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by
clinical decline in memory and other cognitive functions. A classic AD neuropathological …

Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer's Disease

MK Taylor, DK Sullivan, JE Keller… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by
clinical decline in memory and other cognitive functions. A classic AD neuropathological …

Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer's Disease.

MK Taylor, DK Sullivan, JE Keller, JM Burns… - Frontiers in …, 2022 - europepmc.org
Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by
clinical decline in memory and other cognitive functions. A classic AD neuropathological …
[HTML] nih.gov

[HTML][HTML] Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer's Disease

MK Taylor, DK Sullivan, JE Keller, JM Burns… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by
clinical decline in memory and other cognitive functions. A classic AD neuropathological …
[HTML] frontiersin.org

[HTML][HTML] Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer's Disease

MK Taylor, DK Sullivan, JE Keller, JM Burns… - Frontiers in …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by
clinical decline in memory and other cognitive functions. A classic AD neuropathological …